×
About 7,500 results

ALLMedicine™ Angioedema Center

Research & Reviews  3,235 results

COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375290
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology; Lockey RF, Hudey SN

Jul 27th, 2020 - COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids.|2020|Lockey RF,Hudey SN,|

C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case se...
https://doi.org/10.1016/j.japh.2020.06.025
Journal of the American Pharmacists Association : JAPhA; Ibarra F, Cruz M

Jul 25th, 2020 - Review 4 patients who presented with presumed lisinopril-induced angioedema and received C1 esterase inhibitor (C1-INH). Four patients received C1-INH for presumed lisinopril-induced angioedema. In all cases, angioedema was attributed to lisinopri...

Gastrointestinal manifestations of angioedema: a potential area of misdiagnosis.
https://doi.org/10.1097/MEG.0000000000001848
European Journal of Gastroenterology & Hepatology; Mormile I, Cocchiaro A et. al.

Jul 22nd, 2020 - Abdominal pain is one of the most common conditions leading people to the emergency department. An uncommon but well described cause of abdominal pain is angioedema of the gastrointestinal tract due to recurrent angioedema without wheals. Abdomina...

Hereditary C1 inhibitor deficiency associated with systemic lupus erythematosus.
https://doi.org/10.1177/0961203320935980
Lupus Shukla A, Gaur P

Jul 13th, 2020 - Here, we report a family with two children (the elder son and younger daughter) diagnosed with juvenile-onset systemic lupus erythematosus (SLE) and the father diagnosed with hereditary angioedema. Serum C1 inhibitor (C1-INH) levels were low, and ...

Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342472
BMJ Case Reports; Hassan K

Jul 9th, 2020 - This is a case of a patient who presented with an urticarial rash 48 hours before developing symptoms of fever and a continuous cough. She subsequently developed angioedema of her lips and hands before testing positive for severe acute respiratory...

see more →

Guidelines  17 results

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2...
https://doi.org/10.1111/all.13384
Allergy Maurer M, Magerl M et. al.

Jan 10th, 2018 - Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. I...

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology; Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

The diagnosis and management of acute and chronic urticaria: 2014 update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.

Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.

A consensus parameter for the evaluation and management of angioedema in the emergency ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100605
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine; Moellman JJ, Bernstein JA et. al.

Apr 15th, 2014 - Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioed...

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, an...
https://doi.org/10.1016/j.jaci.2013.03.034
The Journal of Allergy and Clinical Immunology; Zuraw BL, Bernstein JA et. al.

Jun 3rd, 2013 - These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council ...

see more →

Drugs  397 results see all →

Clinicaltrials.gov  3,699 results

Carbinoxamine maleate - carbinoxamine maleate tablet-Breckenridge Pharmaceutical, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1edca669-8879-408a-b09c-259e363dd95c

Jul 31st, 2020 - Carbinoxamine maleate is effective for the symptomatic treatment of: Seasonal and perennial allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urt...

COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375290
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology; Lockey RF, Hudey SN

Jul 27th, 2020 - COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids.|2020|Lockey RF,Hudey SN,|

Cyproheptadine hydrochloride - cyproheptadine hydrochloride tablet-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03e69414-8a25-4ed8-b7ac-16445b879b1f

Jul 26th, 2020 - Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or pl...

Promethazine hydrochloride - promethazine hydrochloride tablet-Clinical Solutions Wholesale
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17f72b60-87e8-4d1e-b3f5-2f8a944f5478

Jul 25th, 2020 - Promethazine hydrochloride tablets are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioed...

C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case se...
https://doi.org/10.1016/j.japh.2020.06.025
Journal of the American Pharmacists Association : JAPhA; Ibarra F, Cruz M

Jul 25th, 2020 - Review 4 patients who presented with presumed lisinopril-induced angioedema and received C1 esterase inhibitor (C1-INH). Four patients received C1-INH for presumed lisinopril-induced angioedema. In all cases, angioedema was attributed to lisinopri...

see more →

News  143 results

Recurrent Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Refractory to Fresh Frozen Plasma
https://www.mdedge.com/fedprac/article/213630/hospital-medicine/recurrent-angiotensin-converting-enzyme-inhibitor-induced/page/0/1?channel=327

Dec 5th, 2019 - Discussion The standard therapy for ACEI-inducedangioedema continues to be airway management and discontinuation of medication. However, life-threatening progression of symptoms have led to the use of off-label therapies, including FFP and bradyki.

HAE Attacks Cut With Lanadelumab
https://www.medpagetoday.com/rheumatology/generalrheumatology/76622

Nov 30th, 2018 - Action Points Patients with type I or type II hereditary angioedema (HAE) suffer from regular, unpredictable and life-disrupting attacks, and patients are in need of better drugs to control this lifelong disabling condition. Patients whose HAE is ...

Trial Data Back Lanadelumab for HAE Prevention
https://www.medpagetoday.com/rheumatology/generalrheumatology/76542

Nov 27th, 2018 - Prophylactic treatment with lanadelumab (Takhzyro) prevented hereditary angioedema attacks and led to a clinically-meaningful impact on quality of life, according to the pivotal HELP trial that led to recent FDA approval. The monoclonal antibody c...

FDA Approves 6th Drug for HAE
https://www.medpagetoday.com/rheumatology/generalrheumatology/74729

Aug 24th, 2018 - WASHINGTON -- A monoclonal antibody drug for hereditary angioedema (HAE) won FDA approval late Thursday, making it the sixth agent to reach the U.S. market for the rare genetic disorder. Lanadelumab (Takhzyro), made by Shire, was approved for prev...

FDA approves new treatment for rare hereditary disease
https://www.fda.gov/Drugs/DrugSafety/ucm618261.htm

The U.S. Food and Drug Administration today approved Takhzyro (lanadelumab), the first monoclonal antibody approved in the U.S. to treat patients 12 years and older with types I and II hereditary angioedema (HAE).

see more →

Patient Education  9 results see all →